Related Experiment Video

Updated: Jun 10, 2026

Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
14:05

Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses

Published on: January 23, 2017

[Hiperbilirubinemia- one of the high risk factor influence on hearing level in infants]

Małgorzata Smiechura1, Agata Makowska Piontek, Andrzej Makowski

  • 1Klinika Otolaryngologii Instytutu, Centrum Zdrowia Matki Polki w Łodzi.

Przeglad Lekarski
|August 7, 2010
PubMed

Insights

Hiperbilirubinemia, a condition of high bilirubin levels in infants, is a significant risk factor for hearing loss. However, this study found that elevated bilirubin alone does not impact hearing loss in children.

Area of Science:

  • Neonatal care
  • Pediatric audiology
  • Clinical diagnostics

Context:

  • Infant hearing loss is a major concern, with hiperbilirubinemia identified as a potential risk factor.
  • Previous research suggests a link between high serum bilirubin levels and auditory impairment in newborns.
  • This study investigates the specific relationship between bilirubin levels and hearing outcomes in infants.

Purpose:

  • To determine the influence of serum bilirubin levels on the incidence of hearing loss in infants.
  • To analyze audiological and otolaryngological findings in relation to hiperbilirubinemia.
  • To assess whether isolated high bilirubin levels are a direct cause of hearing impairment.

Summary:

  • Audiologic and otolaryngological examinations were conducted on 53 infants.
  • Hiperbilirubinemia was identified as the sole high-risk factor for hearing loss in the studied group.
  • The analysis concluded that elevated serum bilirubin levels, in isolation, do not independently cause hearing loss.

Impact:

  • Findings challenge the direct causal link between hiperbilirubinemia and infant hearing loss when considered alone.
  • Highlights the need for comprehensive risk assessment beyond just bilirubin levels for infant hearing.
  • Informs clinical practice regarding the evaluation and management of hearing risk in newborns with jaundice.

More Related Videos

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages09:09

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages

Published on: April 11, 2025

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...